Device type · MQV
Filler, Bone Void, Calcium Compound
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MQV
Orthopedic
Device class
Class II
FDA decisions since 2015
180
510(k), De Novo and PMA
Adverse event reports
84
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Filler, Bone Void, Calcium Compound
- Product code
- MQV
- Device class
- Class II
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3045
- Specialty
- Orthopedic Surgery
- FDA record
- Classification database entry for MQV
Latest FDA decisions
The 8 newest of 180 since 2015.
- PearlBone Putty 1600510(k)
K260496 · Decided Nov 2, 2026 · 262 days after receipt
Device type: Filler, Bone Void, Calcium Compound (MQV) · Orthopedic Surgery
K262230 · Decided Sep 11, 2026 · 73 days after receipt
Device type: Filler, Bone Void, Calcium Compound (MQV) · Orthopedic Surgery
- Device 300419 Strip510(k)
K260364 · Decided Jun 2, 2026 · 118 days after receipt
Device type: Filler, Bone Void, Calcium Compound (MQV) · Orthopedic Surgery
177 more FDA decisions with a free account
Reports received
84
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
21
25% of reports
Injury reports
61
73% of reports
Death reports
1
1.2% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 3 | 0 | 0 |
| Jan 24 | 0 | 6 | 0 | 0 |
| Feb 24 | 1 | 7 | 0 | 0 |
| Mar 24 | 0 | 3 | 0 | 0 |
| Apr 24 | 0 | 7 | 0 | 0 |
| May 24 | 3 | 11 | 0 | 0 |
| Jun 24 | 2 | 4 | 0 | 0 |
| Jul 24 | 1 | 3 | 1 | 0 |
| Aug 24 | 0 | 3 | 0 | 0 |
| Sep 24 | 0 | 4 | 0 | 0 |
| Oct 24 | 0 | 7 | 0 | 0 |
| Nov 24 | 0 | 1 | 0 | 0 |
| Dec 24 | 1 | 2 | 1 | 0 |
| Jan 25 | 1 | 1 | 0 | 0 |
| Feb 25 | 0 | 1 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 2 | 1 | 0 | 0 |
| May 25 | 0 | 3 | 0 | 0 |
| Jun 25 | 0 | 11 | 1 | 0 |
| Jul 25 | 6 | 11 | 0 | 0 |
| Aug 25 | 1 | 3 | 0 | 0 |
| Sep 25 | 1 | 2 | 0 | 0 |
| Oct 25 | 2 | 2 | 0 | 0 |
| Nov 25 | 1 | 2 | 0 | 0 |
| Dec 25 | 0 | 5 | 0 | 0 |
| Jan 26 | 1 | 5 | 0 | 0 |
| Feb 26 | 1 | 12 | 0 | 0 |
| Mar 26 | 2 | 2 | 0 | 0 |
| Apr 26 | 2 | 5 | 0 | 0 |
| May 26 | 2 | 8 | 0 | 0 |
| Jun 26 | 2 | 2 | 0 | 0 |
| Jul 26 | 2 | 3 | 0 | 0 |
| Aug 26 | 3 | 12 | 1 | 1 |
| Sep 26 | 4 | 1 | 0 | 0 |
| Oct 26 | 1 | 4 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
7 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem31
- Insufficient Device Problem Information13
- Fracture8
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions19
- Insufficient Information12
- Unspecified Infection10
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- OsteoBallast, 45 x 17.5 mm (SeaSpine Brand), REF: 56800095. Ballast, 45 x 17.5 mm (IsoTis Brand), REF: 02-8000-095Open, Classified
Z-2820-2026 · Started Jul 2, 2026 · Posted by FDA Jul 28, 2026
Reason given: Demineralized bone matrix (DBM) in resorbable mesh indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis, were filled with approx. 4.5 cc DBM (fill for 45 11 mm configuration) instead of approx. 7.5 cc DBM (fill for 45 17.5 mm configuration), which may lead to delayed fusion,...
Cause as FDA categorized it: Process control
- BioCera Fibers, Bioresorbable Bone Void Filler, REF: ORB-0320C-KC, ORB-0310C-KC, ORB-0304C-KC, ORB-0302C-KC, ORB-0305D-KCOpen, Classified
Z-2131-2026 · Started Mar 25, 2026 · Posted by FDA May 7, 2026
Reason given: Resorbable bone void filler falls outside standard specifications.
Cause as FDA categorized it: Device Design
- ZENBONE, REF: ORB-0320C-Z, ORB-0310C-Z, ORB-0304C-ZOpen, Classified
Z-2132-2026 · Started Mar 25, 2026 · Posted by FDA May 7, 2026
Reason given: Resorbable bone void filler falls outside standard specifications.
Cause as FDA categorized it: Device Design
117 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.